Chiesi Ventures

company

About

Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders.

  • 1 - 10

Highlights

Details

Industries
Venture Capital
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
Venture Capital

Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders. The company funds research and development opportunities for therapies of rare diseases and aims to improve the quality of diagnosis, disease management, care and therapy to all patients affected by rare diseases. It also aims to accelerate the expansion of the Chiesi network in the U.S. among universities, venture capital investors, rare disease patient organizations, and entrepreneurial companies developing treatments for rare diseases.

On September 2, 2014, Chiesi Ventures and A. M. Pappas & Associates announced a strategic collaboration.

Chiesi Ventures was founded on September 2, 2014, and is headquartered in Parma, Italy with presence in the United States. It is owned by Chiesi Group.

Investments

Number of Investments
Number of Lead Investments
3
0
Chiesi Ventures has made 3 investments. Their most recent investment was on Mar 22, 2021, when Aura Biosciences raised $80M.
Date Company Name
Round Money Raised Industry Lead Investor
Mar 22, 2021 Aura Biosciences
Series Unknown $80M Biotechnology
Dec 21, 2017 Aura Biosciences
Series C $30M Biotechnology
Mar 5, 2015 Aura Biosciences
Series B $21M Biotechnology